CLINICAL_TRIALS
ClinicalTrials.gov record update
Observational Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06312644
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:29:09.473038+00:00
- Published At
- 2026-04-16T00:00:00+00:00
- Record Updated At
- 2026-04-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Ultomiris-exposed Pregnant/ Postpartum", "Pregnancy", "Paroxysmal Nocturnal Hemoglobinuria (PNH)", "Atypical Hemolytic Uremic Syndrome (aHUS)", "Generalized Myasthenia Gravis (gMG)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-16"- protocolSection.identificationModule.nctId
"NCT06312644"- protocolSection.identificationModule.officialTitle
"Observational Study of Ultomiris\u00ae (Ravulizumab) Safety in Pregnancy"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.